53 reports

Global Cholesterol Testing Industry CHOLESTEROL TESTING MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I.

  • Cholesterol
  • Chronic Disease
  • Europe
  • United States
  • World

Lipid Panel Test/ Complete Lipid Profile Total Cholesterol Test HDL Cholesterol Test LDL Cholesterol Testing Triglycerides/ VLDL Cholesterol Testing B.

  • Cholesterol
  • Europe
  • Japan
  • United States
  • World
  • POC Cholesterol Self-Testing
  • POC Cholesterol Professional Testing
  • Cholesterol
  • Point Of Care Testing
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS

Cholesterol Test Volume and Sales Forecasts 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations List of Tables France: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: Cholesterol Test Volume and Diagnostics Sales Forecasts

  • Cholesterol
  • Japan
  • United States
  • Market Segment
  • Market Size

HDL Cholesterol Test Volume and Sales Forecasts 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations List of Tables France: HDL Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: HDL Cholesterol Test Volume and Diagnostics Sale

  • Cholesterol
  • Japan
  • United States
  • Market Segment
  • Market Size
  • CHOLESTEROL ABSORPTION INHIBITORS
  • GLOBAL CHOLESTEROL ABSORPTION INHIBITORS MARKET 2016-2021 ($ MILLIONS)
  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • Cholesterol and cardiovascular risk
  • Evidence for cholesterol-lowering effects of sterols and stanols
  • Cholesterol
  • Europe
  • Danone SA
  • Raisio Group
  • Unilever PLC

Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Italy: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Japan: Cholesterol Test Vo

  • Cholesterol
  • France
  • Germany
  • Market Segment
  • Market Size
  • Growing demand from emerging markets
  • Global beta-sitosterol market
  • Cholesterol
  • World
  • Forecast
  • Archer Daniels Midland Company
  • Cargill Inc.
  • PRESENTS THE CHOLESTEROL SYNTHESIS PATHWAY, HIGHLIGHTING THE MECHANISM OF ACTION OF STATINS.
  • DYSLIPIDEMIA: FREDRICKSON CLASSIFICATION SYSTEM
  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company
  • 07.2 MECHANISM OF ACTION
  • 07.3 CLINICAL APPLICATION
  • Cholesterol
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Risk Factors and Comorbidities for Dyslipidemia
  • Executive Summary

These lipids include low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C).

  • Cholesterol
  • China
  • Germany
  • Japan
  • Forecast
  • CHOLESTEROL TESTING SERVICES MARKET
  • CHOLESTEROL TESTING/CHOLESTEROL SCREENING SERVICES MARKET, BY TYPE OF CUSTOMER
  • Cholesterol
  • United States
  • Forecast
  • Market Size
  • OPKO Health, Inc.

The others segment encompasses market analysis of combination drug therapies such as Advicor, Vytorin, and Caduet, as well as cholesterol inhibitor drugs.

  • Cholesterol
  • Therapy
  • World
  • Forecast
  • Market Size
  • SUMMARIZES THE LEADING BRANDED DRUGS USED TO TREAT DYSLIPIDEMIA.
  • 9.4.3 DRUGS INCLUDED IN EACH THERAPEUTIC CLASS
  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • NOV 13, 2014: GALMED PHARMACEUTICALS ANNOUNCES FIRST ADMINISTRATION OF ARAMCHOL IN ITS PHASE IIA TRIAL FOR THE TREATMENT OF CHOLESTEROL GALLSTONES
  • Aramchol - Drug Profile
  • Cholesterol
  • United States
  • Company
  • Product Initiative
  • Galmed Pharmaceuticals Ltd.
  • Jun 04, 2014: Recently Published Independent Research Supports the Importance of Reverse Cholesterol Transport on NASH Pathogenesis
  • Nov 13, 2014: Galmed Pharmaceuticals Announces First Administration of Aramchol in its Phase IIa Trial for the Treatment of Cholesterol Gallstones
  • Cholesterol
  • United States
  • Company
  • Product Initiative
  • Galmed Pharmaceuticals Ltd.
  • SUMMARIZES THE LEADING BRANDED DRUGS USED TO TREAT DYSLIPIDEMIA.
  • 9.4.3 DRUGS INCLUDED IN EACH THERAPEUTIC CLASS
  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SUMMARIZES THE LEADING BRANDED DRUGS USED TO TREAT DYSLIPIDEMIA.
  • 9.4.3 DRUGS INCLUDED IN EACH THERAPEUTIC CLASS
  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SUMMARIZES THE LEADING BRANDED DRUGS USED TO TREAT DYSLIPIDEMIA.
  • 9.4.3 DRUGS INCLUDED IN EACH THERAPEUTIC CLASS
  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 5.4.3 DRUGS INCLUDED IN EACH THERAPEUTIC CLASS
  • 4.3.13 MERCK & CO.
  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • DEC 19, 2016: CAPSTONE THERAPEUTICS ANNOUNCES PROFOUND, RAPID LDL CHOLESTEROL REDUCTION IN AEM-28-14 PRIMATE STUDY
  • 02/21/2017: UAB DEVELOPING NEW PEPTIDE TO COMBAT A DISORDER THAT CAUSES HEART ATTACKS AT EARLY AGE
  • Cholesterol
  • Chronic Disease
  • United States
  • Deals & Alliance
  • LipimetiX Development LLC
  • Nov 03, 2009: FDA Turns Down Merck's Application For Combo Cholesterol Pill Involving Lipitor
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns
  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative
  • 05/24/2016: NEW CHOLESTEROL TREATMENT NOW AVAILABLE FOR CANADIANS
  • JUN 22, 2016: NICE GREEN LIGHTS CHOLESTEROL-LOWERING TREATMENT PRALUENT (ALIROCUMAB) FOR NHS FUNDING
  • Cholesterol
  • Therapy
  • United States
  • Company Financials
  • Regeneron Pharmaceuticals, Inc.
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns
  • Nov 03, 2009: FDA Turns Down Merck's Application For Combo Cholesterol Pill Involving Lipitor
  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • CHOLESTEROL POP TEST - PRODUCT DESCRIPTION
  • CHOLESTEROL POP TEST - PRODUCT STATUS
  • Cholesterol
  • Clinical Trial
  • Infectious Disease
  • United States
  • GlobalData's company
  • SMALL MOLECULE TO ANTAGONIZE FARNESOID X RECEPTOR FOR DYSLIPIDEMIA - DRUG PROFILE
  • CER-209 - DRUG PROFILE
  • Cholesterol
  • Obesity
  • Pharmaceutical
  • Statins
  • Esperion Therapeutics, Inc.
  • CSL LIMITED
  • Apolipoprotein A I (APOA1) - Drug Profiles
  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis
  • THERE WAS A SIGNIFICANT INCREASE IN CHOLESTEROL EFFLUX IN DALCETRAPIB-TREATED AA POPULATION, BUT NOT THE GG GENOTYPE
  • BESIDES REQUIRING FREQUENT INJECTIONS, PCSK9 ANTIBODIES WILL LIKELY BE EXPENSIVE AND HAVE NOT SHOWN ANY BENEFICIAL EFFECT ON CHOLESTEROL EFFLUX."
  • Cardiology
  • Cardiovascular Disease
  • Cholesterol
  • Hospital
  • Pfizer Inc.
  • PIPELINE BY ESPERION THERAPEUTICS, INC., H1 2016
  • CSL LIMITED
  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis